Full name
"ESKULAP" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.21.Z - General medical practice
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
86.10.Z - Hospital activities
86.22.Z - Specialist medical practice
86.23.Z - Dental practice
86.90.A - Healthcare
86.90.C - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,3 | 0,1 | 0 | -10,5 |
Gross profit (loss) | 0,3 | 0 | 0,2 | 395,4 |
EBITDA | 0,4 | 0,1 | 0,2 | 191,4 |
Short time liabilities | 0,3 | 0,3 | 0,5 | 33,8 |
Other operating costs | 0 | 0 | 0,1 | 584 |
Equity capital | 0,8 | 0,7 | 0,9 | 22,9 |
Operating profit (EBIT) | 0,3 | 0 | 0,2 | 353,5 |
Assets | 1,2 | 1,2 | 1,4 | 18,7 |
Net profit (loss) | 0,3 | 0 | 0,2 | 398 |
Cash | 0,5 | 0,4 | 0,3 | -20,8 |
Liabilities and provisions for liabilities | 0,3 | 0,5 | 0,5 | 12 |
Net income from sale | 5,6 | 5,7 | 6,7 | 17,1 |
Working assets | 1 | 1 | 1,1 | 12,5 |
Other income costs | 0 | 0 | 0,2 | 20 058,1 |
Depreciation | 0,1 | 0 | 0,1 | 38,7 |
% | % | % | p.p. | |
Profitability of capital | 32,7 | 4,6 | 18,6 | 14 |
Equity capital to total assets | 71,5 | 62,1 | 64,3 | 2,2 |
Gross profit margin | 5,4 | 0,6 | 2,5 | 1,9 |
EBITDA Margin | 6,4 | 1,4 | 3,6 | 2,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 20 | 22 | 25 | 3 |
Current financial liquidity indicator | 3.345607042312622 | 2.788163661956787 | 2.3437564373016357 | -0,5 |
Net dept to EBITDA | -1.3381214141845703 | -3.9022696018218994 | -1.2085014581680298 | 2,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane